Associated Press: Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082
February 6, 2026
Associated Press: Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082
yahoo! news: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
February 6, 2026
John Sarantopoulos, MD, associate professor, Department of Medicine, Division of Hematology and Oncology, and medical oncologist, Mays Cancer Center, was mentioned in this article. Read More
MSN.com: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
February 6, 2026
MSN.com: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
KSAT 12: South Texas amputee hopeful after launch of breakthrough program at UT Health San Antonio
February 6, 2026
KSAT 12: South Texas amputee hopeful after launch of breakthrough program at UT Health San Antonio
KENS 5: Healthy SA — Reducing both obesity and colon cancer risk with GLP-1s
February 4, 2026
KENS 5: Healthy SA — Reducing both obesity and colon cancer risk with GLP-1s
UT Health San Antonio researchers lead American Heart Association scientific statement on early recognition, intervention for post-stroke spasticity
February 4, 2026
Two researchers at UT Health San Antonio led the writing group for a new scientific statement focused on post-stroke spasticity for the American Heart Association. The statement urges a shift in how post-stroke spasticity is recognized and treated, emphasizing early diagnosis, timely intervention and innovative therapies to reduce long-term disability and improve recovery after stroke.
